194 related articles for article (PubMed ID: 33538569)
21. [Topical cytostatic treatment of epitheliomas with a 5 per cent 5-fluorouracil ointment].
Ebner H
Z Haut Geschlechtskr; 1968 Sep; 43(18):757-62. PubMed ID: 5715906
[No Abstract] [Full Text] [Related]
22. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
Philipp-Dormston WG; Müller K; Novak B; Strömer K; Termeer C; Hammann U; Glutsch JW; Krähn-Senftleben G; Lübbert H; Koller M; Szeimies RM;
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1138-1146. PubMed ID: 29150868
[TBL] [Abstract][Full Text] [Related]
23. 5-fluouracil (5-FU) ointment in the treatment of skin tumours and keratoses.
Almeida Gonçalves JC; De Noronha T
Dermatologica; 1970; 140():Suppl 1:97+. PubMed ID: 5471370
[No Abstract] [Full Text] [Related]
24. Malignant potential of keratoacanthoma.
Butcher RB
Laryngoscope; 1979 Jul; 89(7 Pt 1):1092-8. PubMed ID: 449552
[TBL] [Abstract][Full Text] [Related]
25. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
26. A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers.
Nahm WJ; Shen J; Zito PM; Gonzalez AM; Nagrani N; Moore K; Badiavas EV; Kirsner RS; Nichols AJ
J Drugs Dermatol; 2021 Mar; 20(3):260-267. PubMed ID: 33683072
[TBL] [Abstract][Full Text] [Related]
27. No chemopreventive effect of nonsteroidal anti-inflammatory drugs on nonmelanoma skin cancer: evidence from meta-analysis.
Zhang B; Liang X; Ye L; Wang Y
PLoS One; 2014; 9(5):e96887. PubMed ID: 24828489
[TBL] [Abstract][Full Text] [Related]
28. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
29. The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma.
Orenberg EK; Miller BH; Greenway HT; Koperski JA; Lowe N; Rosen T; Brown DM; Inui M; Korey AG; Luck EE
J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):723-8. PubMed ID: 1430394
[TBL] [Abstract][Full Text] [Related]
30. Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma.
Goldenhersh MA; Olsen TG
J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):372-8. PubMed ID: 6368620
[TBL] [Abstract][Full Text] [Related]
31. [Topical therapy of precancerous lesions and skin carcinomas using a 5-fluorouracil ointment].
Uthida-Tanaka AM; Nakamura S; de Britto-Costa R; de Tavares Mello E
Hospital (Rio J); 1969 Dec; 76(6):2207-20. PubMed ID: 5309543
[No Abstract] [Full Text] [Related]
32. Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies.
Rudnick EW; Thareja S; Cherpelis B
Int J Dermatol; 2016 Mar; 55(3):249-58; quiz 256, 258. PubMed ID: 26566923
[TBL] [Abstract][Full Text] [Related]
33. Update of cetuximab for non-melanoma skin cancer.
Wollina U
Expert Opin Biol Ther; 2014 Feb; 14(2):271-6. PubMed ID: 24387664
[TBL] [Abstract][Full Text] [Related]
34. Non-melanoma skin cancer: new and future synthetic drug treatments.
Amaral T; Garbe C
Expert Opin Pharmacother; 2017 May; 18(7):689-699. PubMed ID: 28414587
[TBL] [Abstract][Full Text] [Related]
35. Differences in tumor microvessel density between squamous cell carcinomas and basal cell carcinomas may relate to their different biologic behavior.
Weninger W; Rendl M; Pammer J; Grin W; Petzelbauer P; Tschachler E
J Cutan Pathol; 1997 Jul; 24(6):364-9. PubMed ID: 9243364
[TBL] [Abstract][Full Text] [Related]
36. Treatment of a giant squamous cell carcinoma on the dominant thumb with intralesional 5-fluorouracil.
Reisinger DM; Cognetta AB; Pynes LT; Paredes AA; Sweeney TJ; Dolson DJ
J Am Acad Dermatol; 2011 Jul; 65(1):219-21. PubMed ID: 21679825
[No Abstract] [Full Text] [Related]
37. Immunolocalization of glioma-associated oncogene homolog 1 in non melanoma skin cancer.
Bakry OA; Samaka RM; Shoeib MA; Megahed DM
Ultrastruct Pathol; 2015 Apr; 39(2):135-46. PubMed ID: 25350271
[TBL] [Abstract][Full Text] [Related]
38. Intratumoral chemotherapy with fluorouracil/epinephrine injectable gel: a nonsurgical treatment of cutaneous squamous cell carcinoma.
Kraus S; Miller BH; Swinehart JM; Shavin JS; Georgouras KE; Jenner DA; Griffin E; Korey A; Orenberg EK
J Am Acad Dermatol; 1998 Mar; 38(3):438-42. PubMed ID: 9520026
[TBL] [Abstract][Full Text] [Related]
39. Pathology of common skin tumors.
Lever WF
J Surg Oncol; 1971; 3(3):235-50. PubMed ID: 5110332
[No Abstract] [Full Text] [Related]
40. Clinical and structural evaluation of the treatment of some hyperplastic and neoplastic skin diseases with 5-fluorouracil (5-FU) ointment.
Binazzi M
Dermatologica; 1970; 140():Suppl 1:90-6. PubMed ID: 5471369
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]